Cost-Per-Responder Analysis of Bimekizumab (IL-17A/F inhibitor) against IL-17A and IL-12/23 Targeted Therapies for Psoriatic Arthritis in Spain, based on Matching-Adjusted Indirect Comparisons (MAIC)

Congress: ISPOR Europe 2024 Objective: Bimekizumab is an IgG1 monoclonal antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A, recently approved for the treatment of patients with active psoriatic arthritis (PsA) in the European Union. This study compares the cost per responder (CPR) of bimekizumab with therapies targeting IL-17A and IL-12/23 (secukinumab and ustekinumab) […]

Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-23 Targeted Therapies for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons (MAIC)

Congress: ISPOR Europe 2024 Objective: Bimekizumab is an IgG1 monoclonal antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A, recently approved as a treatment for patients with active psoriatic arthritis (PsA) in the European Union. This study compares the cost per responder (CPR) of bimekizumab versus IL-23-targeted therapies (guselkumab and risankizumab) for the treatment […]

Recommendations for effective patient involvement in the assessment of medical devices

Congress: ISPOR Europe 2024 Objective: The aim of the study is to analyse and improve the current process of patient involvement in HTA in Europe and Spain, establishing recommendations that promote effective patient involvement in medical device decisions. This approach aims not only to meet the needs of patients, but also to align assessment processes […]

Budget Impact Analysis of a Solution for Sealant in Spain

Congress: 2022-11, ISPOR Europe 2022, Vienna, Austria. Value in Health, Volume 25, Issue 12S (December 2022) Year: 2022 Category: Economic Evaluation Subcategory: Budget impact analysis Objective:To estimate the budgetary impact (BI) on the Spanish National Health System (NHS) following the introduction of a new fibrin sealant (Veraseal®) for supportive treatment in adults when the usual […]

An ideal and sustainable framework agreement for the public procurement of vaccines in Spain

Congress: ISPOR Europe 2020 Year: 2020 Subject: Vaccine Procurement Subcategory: Multi-Criteria Decision Analysis (MDCA) Objective: Determine the desirable award criteria and their relative weight that should be included in an ideal and sustainable framework agreement for vaccine procurement in Spain. To compare the ideal framework with the current situation and identify areas for improvement. The […]

Budget IMPACT Analysis of LESS Invasive Surfactant Administration (LISA) Technique As EARLY Rescue Strategy for Preterm Infants with Respiratory Distress Syndrome in Spain

Congress: ISPOR Europe 2020 Year: 2020 Desease: Respiratory disorders Subcategory: Budget impact analysis Objective: To estimate the budgetary impact of early rescue with pulmonary surfactant in preterm infants with Respiratory Distress Syndrome in Spain. The study is in collaboration with Chiesi. DOI: https://doi.org/10.1016/j.jval.2020.08.1888

Budget impact analysis of low-dose methoxyflurane for the treatment of moderate-to-severe trauma pain in conscious adult patients in Spain

Congress: ISPOR BARCELONA Year: 2018 Desease: Pain Subject: Cost study Subcategory:Budgetary Impact Objective: To estimate the budgetary impact for the National Health System (NHS) associated with the introduction of low-dose methoxyflurane (Penthrox®) as an alternative for the emergency relief of moderate to severe pain in conscious adult patients with trauma and associated pain.

Cost-Utility Analysis of the germline BRCA testing in Women with epithelial ovarian cancer without family history in Spain

Congress: ISPOR Year: 2018 Desease: Cancer Subject: Cost study Subcategory:Cost-utility analysis Objective: germline BRCA1 and BRCA2 gene mutations (gBRCA1/2m) are associated with an increased risk of ovarian cancer (OC) and breast cancer (BC). This study estimates the long-term efficiency of providing germline BRCA testing (gBRCAt) in women with high-grade epithelial nonmucinous OC without a family […]